Study name: Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer Surgery (POACC-2)
Study type: Randomized, interventional
Population: Colorectal Cancer patients
Trial number: NCT03700541
Status: Recruiting
Study name: Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery (POACC-1)
Study type: Randomized, interventional
Population: Colorectal Cancer patients
Trial number: NCT03700411
Status: Recruiting
Study name: Biomarkers of Endometrial Receptivity (BIOMER)
Study type: Prospective, interventional
Trial number: NCT04619524
Status: Recruiting
Study name: Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis
Study type: Prospective, observational
Population: Cystic fibrosis and Asthma patients
Trial number: NCT04157361
Status: Recruiting
Study name: Self-sampling for Non-attenders to Cervical Cancer Screening (KOPRETINA)
Study type: Prospective, screening
Trial number: NCT04226313
Status: Recruiting
Study name: Assesment of Multiomics Profiles in Health and Disease (ENIGMA)
Study type: Prospective, observational
Population: Healthy Blood donors
Trial number: NCT04427163
Status: Recruiting
Study name: Phase II Open Labeled Trial of Disulfiram with Copper in Metastatic Breast Cancer
Study type: Phase II open labeled clinical trial
Population: Metastatic breast cancer patients
Protocol number: 2016-1-DSF-MBC
Trial number: 2016-001386-81 (EudraCT), NCT03323346
Status: Recruiting
Study name: HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs
Study type: Prospective, screening
Trial number: NCT04133610
Status: Completed
Study name: Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery
Study type: Prospective, randomized
Population: Patients undergoing collorectal cancer surgery
Trial number: NCT02314871
Status: Recruiting
Study name: A multi-center retrospective study for developing and validating a microRNA based assay for the classification of indeterminate thyroid FNA samples
Study type: Retrospective biomarker identification and validation study
Population: Patients with thyroid diseases, preferrably thyroid cancer
Protocol number: RG-Thyroid-DD-21-28
Status: Terminated
Study name: Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients
Study type: Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients
Population: Patients with Colorectal Cancer
Protocol number: NCT03337347
Status: Completed
Study name: Placebo controlled phase II clinical study of antioxidant lycopene on oxidative stress in cystic fibrosis and male infertility patients.
Study type: Placebo controlled phase II study
Population: Cystic fibrosis patients (pediatric and adults), healthy cystic fibrosis heterozygotes, healthy volunteers and infertile men.
Protocol number: 1A8621
Status: Terminated
Study name: A randomized, single-dose, two-way cross-over study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing atorvastatin.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 176/022/04-iqa
Status: Terminated
Study name: Genomic profiling of locally advanced rectal cancers in prediction of chemotherapy response.
Study type: Prospective biomarker identification and validation study
Population: Rectal cancer patietns
Protocol number: NR9076
Status: Terminated
Study name: Molecular predictive biomarkers of EGFR inhibitors combined with radiotherapy in head and neck cancer patients.
Study type: Prospective biomarker identification and validation study
Population: Head and neck cancer patients
Protocol number: NS10108
Status: Terminated
Study name: Detection and clinical significance of minimal residual disease/circulating tumor cells in patients undergoing surgery for colorectal cancer.
Study type: Prospective biomarker validation study
Population: Stage I-IV colorectal cancer patients
Protocol number: NR7804
Status: Terminated
Study name: Clinical significance of minimal residual disease/circulating tumor cells in pancreatic adenocarcinoma patients.
Study type: Prospective biomarker identification and validation study
Population: Pancreatic adenocarcinoma patients
Protocol number: NS9937
Status: Terminated
Study name: Molecular basis of glucocorticoid response in children acute lymphoblastic leukemia.
Study type: Prospective biomarker identification and validation study
Population: Acute lymphoblastic leukemia children
Protocol number: NS9939
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing citalopram.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 78/013/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing simvastatin.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 77/014/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing pioglitazone.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 78/015/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing glibenclamide (glyburide).
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 77/012/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing azithromycine.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 77/011/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing itraconazole.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 78/016/02-iqa
Status: Terminated
Study name: PROTAXEL PHASE I STUDY. Single - center open study of the toxicity, safety, tolerability and kinetics of individually ascending doses of Protaxel in patients with refractory/recurrent ovarian or prostate cancer.
Study type: Phase I clinical trial
Population: Paclitaxel refractory/recurrent advanced ovarian or prostate cancer patients
Protocol number: PTX-I-01 2001
Status: Terminated
Study name: Clinical Efficacy and Safety of a Cosmetic Topical Agent, Fluridil, in Male Androgenic Alopecia
Study type: Phase II clinical trial
Population: Males with androgenic alopecia
Protocol number: FLUR-2000
Status: Terminated